why choose us

First received: February 07, 2025

Clinical Trial: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Mellitus Type 2

Study Type: INTERVENTIONAL


Official Title: Open-label, Randomized, Two-period Comparative Pharmacokinetics and Bioequivalence Study of Empagliflozin + Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hunga

Brief Summary: Empagliflozin and metformin hydrochloride are two separate drugs.The combination of these two drugs in one tablet are used for the treatment of type 2 diabetes, along with diet and exercise, and can be used with other drugs, if required.It is approved in Russia and also various other countries.In Russia, the brand name is Synjardy®.The purpose of this research study is to measure the amount of the two drugs in the blood after taking two different formulations of the combination tablet.One formulation, also called…

Read more